Publications
Specialty
Search
Today's Wound Clinic, Wound Care
10/15/2024
The proposed policies for calendar year 2025 impact payment for autologous blood-derived products used in wound healing and reimbursement for CTPs, as well as caretaker training services, prior authorization, and more.
Neurology
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and Research in Multiple Sclerosis.
IO Learning
10/15/2024
Ripal Gandhi, MD, FSVM, discusses the new and upcoming approaches for treating locally advanced pancreatic cancer.
EMSWorld, Emergency & Mobile Medicine
10/15/2024
Clarke joined SCCAD in November 2022 and was known for his affable nature and positive energy.
Advances in Inflammatory Bowel Disease Network
10/15/2024
Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.
IO Learning
10/15/2024
Osman Ahmed, MD, discusses the where interventional radiologists might fit in when it comes to intratumor injections for oncology patients.
EMSWorld
10/15/2024
The goals of the K9 program include setting training and certification standards, writing program policy – including K9 crisis response; therapy dogs for a system, team, response, and station; dog etiquette and training, and service dog training to support firefighters struggling with mental health challenges.
Podiatry Today, Podiatry
10/15/2024
The technique described allows the surgeon to restore the Achilles tendon while augmenting the strength of repair with subsequent FHL transfer, avoids donor site morbidity, and addresses the weakness of the posterior musculature group.
First Report Managed Care
10/14/2024
Discover how artificial intelligence may alter mental health support for individuals with rare diseases, as presented at AMCP Nexus 2024, with key insights on the crucial role managed care professionals can play in filling the gap for FDA-approved treatments.
First Report Managed Care
10/14/2024
Multigene panel testing can increase eligibility for targeted therapy in lung and colorectal cancer patients while only representing a small portion of total care costs according to research presented at AMCP Nexus 2024.
First Report Managed Care
10/14/2024
Research presented at AMCP Nexus 2024 examines the impact of deutetrabenazine (DTBZ) on psychiatric stability in patients with tardive dyskinesia, showing a potential improvement in schizophrenia-related hospitalizations and emergency department visits for psychotic events.
First Report Managed Care
10/14/2024
Research presented at AMCP Nexus 2024 suggests that switching to long-acting antiretroviral therapy (ART) may significantly improve adherence and persistence in people with HIV (PWH) compared to staying on traditional oral ART, offering a potential alternative for those who struggle with daily dosing.
First Report Managed Care
10/14/2024
Study findings suggest that a significant proportion of modern idiopathic pulmonary arterial hypertension (IPAH) cases may not exhibit the classic plexiform vasculopathy seen in earlier descriptions of the disease, according to researchers.
Oncology
10/11/2024
True or False: According to phase 2 prospective study results from a multicenter trial, a
Gastroenterology
10/11/2024
Host Brian Lacy, MD, reviews the diagnosis and treatment of acute and chronic constipation with Dr Satish Rao.
Advances in Inflammatory Bowel Disease Network, Gastroenterology
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along with those for influenza, COVID-19, and pneumonia.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
10/11/2024
HeartFlow Plaque Analysis will be covered by four of seven Medicare Administrative Contractors (MAC) beginning November 24, 2024.
Pharmacy Learning Network
10/11/2024
In this installment of Talking Therapeutics, we explore a first-of-its-kind trial evaluating the potential of SGLT2 inhibitors to prevent chemotherapy-related cardiotoxicity.
First Report Managed Care
10/11/2024
Progression-free survival was significantly longer with amivantamab–lazertinib compared with osimertinib as first-line treatment of untreated EGFR (epidermal growth factor receptor)-mutated advanced non-small-cell lung cancer (NSCLC), according to a study published online ahead of print in the New England Journal of Medicine.
Psych Congress Network
10/11/2024
Black box warnings on antidepressants from the FDA warning of increased risk of suicidality were associated with a decline in mental health treatment and an increase in suicide attempts and deaths in young people, according to a systematic review published in Health Affairs.
Reimbursement Library From A to Z
Subscribe and never miss an article!
Today's Wound Clinic Newsletter
